Celldex Therapeutics, Inc. (CLDX) Balance Sheet
As of 2026-06-30 (10-Q), Celldex Therapeutics, Inc. (CLDX) reported total assets of $782.3M, total liabilities of $67.8M and shareholders' equity of $714.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $47.5M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CLDXCelldex Therapeutics, Inc.Follow CLDX — free
—
Price chart with a free account
- Market cap
- 2.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.9 | 24.9 | 169.4 | 28.0 | 72.1 | 42.5 | 40.3 | 24.3 | 11.2 | 43.8 | 39.1 | 29.4 | 34.8 | 28.4 | 28.9 | 47.5 | |
| Short-term investments | 41.4 | 59.1 | 133.6 | 173.0 | 217.8 | 147.3 | 99.1 | 69.7 | 53.2 | 150.6 | 369.1 | 275.5 | 388.8 | 696.9 | 489.7 | 670.1 | |
| Receivables | 0.2 | 0.0 | 0.5 | 0.4 | 1.0 | 1.8 | 1.9 | 3.2 | 1.0 | 1.8 | 0.2 | 0.3 | 2.6 | 0.7 | 2.0 | 0.2 | |
| Current assets | 54.7 | 85.1 | 305.2 | 205.0 | 294.9 | 195.6 | 144.8 | 99.1 | 66.7 | 197.8 | 410.8 | 317.7 | 431.7 | 747.2 | 534.7 | 724.9 | |
| Total assets | 98.0 | 125.5 | 347.1 | 248.0 | 337.6 | 383.4 | 315.6 | 155.8 | 122.9 | 235.8 | 444.7 | 352.7 | 465.6 | 792.3 | 583.0 | 782.3 | |
| Current liabilities | 14.3 | 17.7 | 20.4 | 24.5 | 30.2 | 35.2 | 27.7 | 12.6 | 11.6 | 14.2 | 16.5 | 18.6 | 31.1 | 39.5 | 51.0 | 61.3 | |
| Long-term debt | — | 11.3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Total liabilities | 29.3 | 29.8 | 27.3 | 36.4 | 47.5 | 117.9 | 79.3 | 31.7 | 28.9 | 26.5 | 25.2 | 26.5 | 36.5 | 45.3 | 55.8 | 67.8 | |
| Shareholders' equity | 68.7 | 95.8 | 319.8 | 211.7 | 290.1 | 265.4 | 236.4 | 124.1 | 94.0 | 209.4 | 419.5 | 326.2 | 429.2 | 747.0 | 527.2 | 714.6 |
USD millions · SEC XBRL
Celldex Therapeutics, Inc. — questions
- How much cash does Celldex Therapeutics, Inc. have?
- $47.5M in cash and cash equivalents as of 2026-06-30.
- What are Celldex Therapeutics, Inc.'s total assets?
- $782.3M as of 2026-06-30.
- What is Celldex Therapeutics, Inc.'s shareholders' equity?
- $714.6M as of 2026-06-30.
Every figure on this page comes from Celldex Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.